Leiyang Guo
No. 139, Ziqiang Road
Shijiazhuang, 050051, China
Shijiazhuang, 050051, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
9-Methoxycamptothecin induces proliferating cell nuclear antigen associated factor 15 mediated proliferation inhibition, DNA damage, and apoptosis in melanoma cells.
Journal: Anti-cancer drugs
Published: October 05, 2025
Retraction Note: CSN6 promotes melanoma proliferation and metastasis by controlling the UBR5-mediated ubiquitination and degradation of CDK9.
Journal: Cell death & disease
Published: July 24, 2025
PAF15 drives melanoma progression by promoting proliferation concomitant with suppression of DNA damage and apoptosis: a novel therapeutic vulnerability.
Journal: Neoplasma
Published: July 20, 2025
Tetrandrine targeting SIRT5 exerts anti-melanoma properties via inducing ROS, ER stress, and blocked autophagy.
Journal: Journal of pharmaceutical analysis
Published: January 13, 2024
Morusinol extracted from Morus alba induces cell cycle arrest and apoptosis via inhibition of DNA damage response in melanoma by CHK1 degradation through the ubiquitin-proteasome pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 20, 2022
Corrigendum: Dihydrocapsaicin inhibits cell proliferation and metastasis in melanoma via down-regulating β-catenin pathway.
Journal: Frontiers in oncology
Published: September 23, 2022
ZC3H15 Correlates with a Poor Prognosis and Tumor Progression in Melanoma.
Journal: BioMed research international
Published: May 26, 2021
Dihydrocapsaicin Inhibits Cell Proliferation and Metastasis in Melanoma via Down-regulating β-Catenin Pathway.
Journal: Frontiers in oncology
Published: December 31, 2020
CSN6 promotes melanoma proliferation and metastasis by controlling the UBR5-mediated ubiquitination and degradation of CDK9.
Journal: Cell death & disease
Published: August 25, 2020
Dehydrocorydaline inhibits cell proliferation, migration and invasion via suppressing MEK1/2-ERK1/2 cascade in melanoma.
Journal: OncoTargets and therapy
Published: November 16, 2018
Last Updated: 09/26/2026